These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36395675)

  • 1. Correlations of selenium and selenoprotein P with asymmetric dimethylarginine and lipid profile in patients with polycystic ovary syndrome.
    Amirkhizi F; Khalese-Ranjbar B; Mansouri E; Hamedi-Shahraki S; Asghari S
    J Trace Elem Med Biol; 2023 Jan; 75():127101. PubMed ID: 36395675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Selenium and Circulating Adipokine Levels in Patients with Polycystic Ovary Syndrome.
    Khademi Z; Pourreza S; Hamedi-Shahraki S; Amirkhizi F
    Biol Trace Elem Res; 2024 Aug; 202(8):3442-3448. PubMed ID: 37910262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Selenium Supplementation on Asymmetric Dimethylarginine and Cardiometabolic Risk Factors in Patients with Polycystic Ovary Syndrome.
    Rashidi BH; Mohammad Hosseinzadeh F; Alipoor E; Asghari S; Yekaninejad MS; Hosseinzadeh-Attar MJ
    Biol Trace Elem Res; 2020 Aug; 196(2):430-437. PubMed ID: 31667685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.
    Demirel F; Bideci A; Cinaz P; Camurdan MO; Biberoğlu G; Yesilkaya E; Hasanoğlu A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):129-34. PubMed ID: 17465999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Serum Selenium and Selenoprotein P with Oxidative Stress Biomarkers in Patients with Polycystic Ovary Syndrome.
    Amirkhizi F; Taghizadeh M; Khalese-Ranjbar B; Hamedi-Shahraki S; Asghari S
    Biol Trace Elem Res; 2024 Mar; 202(3):947-954. PubMed ID: 37391553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
    Pirwany IR; Fleming R; Greer IA; Packard CJ; Sattar N
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):447-53. PubMed ID: 11318779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidised low-density lipoprotein concentration - early marker of an altered lipid metabolism in young women with PCOS.
    Macut D; Damjanovic S; Panidis D; Spanos N; Glisic B; Petakov M; Rousso D; Kourtis A; Bjekic J; Milic N
    Eur J Endocrinol; 2006 Jul; 155(1):131-6. PubMed ID: 16793959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L; Pasinetti E
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma selenium levels in Turkish women with polycystic ovary syndrome.
    Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF
    Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction.
    Bayram F; Kocer D; Ozsan M; Muhtaroglu S
    Gynecol Endocrinol; 2012 Jul; 28(7):497-501. PubMed ID: 22703625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress promotes hyperandrogenism by reducing sex hormone-binding globulin in polycystic ovary syndrome.
    Sun Y; Li S; Liu H; Bai H; Hu K; Zhang R; Liu Q; Fan P
    Fertil Steril; 2021 Dec; 116(6):1641-1650. PubMed ID: 34433519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment.
    Heutling D; Schulz H; Nickel I; Kleinstein J; Kaltwasser P; Westphal S; Mittermayer F; Wolzt M; Krzyzanowska K; Randeva H; Schernthaner G; Lehnert H
    J Clin Endocrinol Metab; 2008 Jan; 93(1):82-90. PubMed ID: 17986642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium status parameters in patients with polycystic ovary syndrome.
    Zagrodzki P; Krzyczkowska-Sendrakowska M; Nicol F; Wietecha-Posłuszny R; Milewicz T; Kryczyk-Kozioł J; Chaykivska Z; Jach R
    J Trace Elem Med Biol; 2017 Dec; 44():241-246. PubMed ID: 28965582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome.
    Yildizhan R; Ilhan GA; Yildizhan B; Kolusari A; Adali E; Bugdayci G
    Fertil Steril; 2011 Jul; 96(1):246-50. PubMed ID: 21600576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum selenium and selenoprotein-P levels in autoimmune thyroid diseases patients in a select center: a transversal study.
    Federige MAF; Romaldini JH; Miklos ABPP; Koike MK; Takei K; Portes ES
    Arch Endocrinol Metab; 2017 Dec; 61(6):600-607. PubMed ID: 29412385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.